Xspray Pharma: Follow-Up Comment on Study Results
Research Note
2021-10-13
16:51
Redeye returns with an updated take on Xspray following the disappointing news that HyNap-Dasa “C” did not reach bioequivalence, announced this morning.
FE
Filip Einarsson
Disclosures and disclaimers